Hotline:
+ 49 (0) 2204 2918806

Market studies for category CNS/Neurology

Items 1 to 10 of 470 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 47
  1. Net price*
    Year
  2. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Neonatal Seizures Global Clinical Trials Review, H2, 2014

    GlobalData
    52 pages
    GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Seizures. It includes an overview of the trial numbers and their recruitment statu
    Englisch | Zukunftsanalyse | SKU: 403693
  3. $3,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

    GBI Research
    221 pages
    GBI Research’s report, “Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trend
    Englisch | | SKU: 307598
  4. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Depression - Pipeline Review, H1 2015

    Global Markets Direct
    455 pages
    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2015’, provides an overview of the Depression’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of act
    Englisch | Zukunftsanalyse | SKU: 987678259
  5. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Tourette Syndrome - Pipeline Review, H1 2014

    Global Markets Direct
    79 pages
    Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H1 2014’, provides an overview of the Tourette Syndrome’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Tourette Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug tar
    Englisch | Zukunftsanalyse | SKU: 393752
  6. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Partial Seizure - Pipeline Review, H1 2015

    Global Markets Direct
    89 pages
    Global Markets Direct’s, ‘Partial Seizure - Pipeline Review, H1 2015’, provides an overview of the Partial Seizure’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Partial Seizure, complete with comparative analysis at various stages, therapeutics assessment by drug target, m
    Englisch | Zukunftsanalyse | SKU: 987688248
  7. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022

    GlobalData
    44 pages
    Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have
    Englisch | Zukunftsanalyse | SKU: 402549
  8. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    CNV-1014802 (Neuropathic Pain) - Forecast and Market Analysis to 2022

    GlobalData
    86 pages
    Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the term neuropa
    Englisch | Zukunftsanalyse | SKU: 402963
  9. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014

    GlobalData
    54 pages
    GlobalData's clinical trial report, “Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014" provides data on the Dysgeusia (Taste Disorders) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysgeusia (Taste Disorders). It includes an overview of the trial numbe
    Englisch | Zukunftsanalyse | SKU: 403378
  10. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Osteoarthritis Pain - Pipeline Review, H1 2014

    Global Markets Direct
    169 pages
    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2014’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Osteoarthritis Pain, complete with comparative analysis at various stages, therapeutics assessment by dr
    Englisch | Zukunftsanalyse | SKU: 403943
  11. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    EpiCast Report: Multiple Sclerosis Epidemiology Forecast to 2022

    GlobalData
    56 pages
    Introduction Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and symptoms. MS affects 2.5 million people worldwide each year and is the most debilitating neurological disease in young adults (Fernand
    Englisch | Report | SKU: 329211

Items 1 to 10 of 470 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 47